Wholesale Investors only

open

LSF

Fund overview

Essential life sciences infrastructure supported by resilient, long-term sector demand

APIR Code: MAQ8914AU

Charter Hall Direct Life Sciences Fund (LSF) is a fixed-term unlisted property fund investing in a world-class integrated pathology diagnostic facility in Australia.

LSF provides exposure to essential life sciences infrastructure supported by resilient, long-term sector demand, with a target total return of +13% p.a*. over a five-year investment term.

The Property is 100% leased to Sullivan Nicolaides Pty Ltd, a wholly owned subsidiary of ASX-listed Sonic Healthcare Limited, one of the world's largest providers of medical diagnostic services, and benefits from a weighted average lease expiry (WALE) of 20 years.

LSF provides access to a high-quality institutional asset with contracted CPI-linked annual rental increases, a triple net lease and the potential for capital growth.

Invest now Investor Portal Login

Open for investment

+13% p.a.

Target return (5 year)*

20.0 years

WALE

100%

Occupancy

Important Information

What is life sciences real estate?

Life sciences real estate is characterised by facilities used for scientific research, healthcare and innovation. The sector provides essential, non-discretionary services supported by resilient, long-term demand drivers, including an ageing population, advances in diagnostics and early detection, and increasing healthcare expenditure.

Why LSF

Exposure to essential life sciences infrastructure supported by resilient, long-term sector demand
Access to a high-quality institutional asset with a 20-year lease term and contracted CPI-linked annual rental increases
100% leased to Sullivan Nicolaides Pty Ltd, a wholly owned subsidiary of ASX-listed Sonic Healthcare Limited

Take a closer look at the asset

Limited Offer of bonus Wholesale Units for early investors

Under a Limited Offer, Applicants whose application monies form part of the first $30 million received, will receive 2.0% bonus Wholesale Units.*

*Bonus Wholesale Units: Under the Limited Offer, Applicants whose application monies form part of the first $30,000,000 (or such other amount as the Responsible Entity determines) received by the Responsible Entity and in respect of which no Equity Raising Fee is payable in connection with their application, may receive 2.0% bonus Wholesale Units. By way of example, an Investor may be issued an additional 2,000 bonus Wholesale Units for every 100,000 Wholesale Units subscribed for (equating to 102,000 Wholesale Units for every $100,000 invested). Refer to the Information Memorandum for more information.

Why Australian life sciences real estate? Why now?

Critical life sciences infrastructure

Life sciences assets support scientific research, diagnostics, healthcare and innovation, providing essential healthcare infrastructure.

Structural demand drivers

Ageing populations, rising healthcare expenditure and increasing testing complexity are generating sustained demand.

High barriers to entry

Significant capital requirements, specialised facilities and stringent regulation constrain new supply.

Learn more about the life sciences opportunity

Important information

Offer opening date	10 August 2026
First Allotment Date	On or around 7 September 2026 Subsequent allotment dates will occur daily during the Allotment Period.
First distribution period	The Responsible Entity intends to pay the first income distribution in mid-February 2027 in relation to the period from the first Allotment Date to 31 December 2026.
Minimum Application Amount	$100,000 The Responsible Entity may waive the minimum Application Amount requirements in its discretion.
Eligibility	The Fund is open to investment by Wholesale Clients only, being a person or entity that is not a 'retail client' under section 761G of the Corporations Act. This commonly includes a person or entity: that has obtained a qualified accountant’s certificate stating they have net assets of at least $2.5 million, or a gross income for each of the last two financial years of at least $250,000; or a professional investor; or investors who invest at least $500,000 in a single offer.

All dates are subject to change and are at the discretion of the Responsible Entity. In addition, the Responsible Entity may increase or decrease the Total Offer Amount in its discretion, in which case there will be a commensurate increase or decrease in the Fund's holding in the Underlying Fund.

Download the Information Memorandum

Looking to invest? Here’s how

Read

Read the Information Memorandum in full.

Consider

Consider the offer, paying particular attention to the risks set out in the Information Memorandum.

Consult

Consult your financial adviser, stockbroker and other professional adviser.

Access

Access our online applications or complete the paper copy accompanying the IM.

Apply now

Contact Us

Financial Advisers, Wealth Groups and Family Offices

Scott McLennan

Head of Distribution

Melissa Ridley

National Strategic Account Manager

Marco Triani

State Distribution Manager (NSW/Qld)

Craig Harding

Senior Business Development Manager (Vic/SA/WA/Tas)

Lachlan Ryan

Business Development Manager (Vic/SA/WA)

Sam Kneipp

Business Development Manager

Sally Chen

Business Development Manager

Sandhya Reddy

Account Manager

High-Net-Worth and Direct Investors

Oliver Gordon

Investor Communications Executive

Sarah Bohill

Investor Communications Executive

Charter Hall

Enquiries

Important Information

*The target return is a target only. It is not a forecast and might not be achieved.

This website is issued by Charter Hall Direct Property Management Limited ABN 56 073 623 784 AFSL 226849 (CHDPML) as the issuer of units in the Charter Hall Direct Life Sciences Fund (Fund). The Information Memorandum (IM) for the Fund is available at www.charterhall.com.au. An investment is subject to risks which are summarised in the IM (Offer Document). You should consider the Offer Document and any supplementary Offer Document in deciding whether to acquire or continue to hold the product. This website is not an offer of units in the Fund or an offer to buy or sell any financial product and should not be relied on in making an investment decision. The information is general in nature and does not take into account your investment objectives, particular needs or financial situation. You should seek independent financial advice. Applications to invest can only be made using the application form relevant to the product. You can obtain a copy of the Offer Document and application form from www.charterhall.com.au or by calling 1300 652 790. You can only apply to invest in the Fund if you are a wholesale client (within the meaning of that term under the Corporations Act 2001 (Cth)). Whilst all care has been taken in preparation of this website CHDPML does not give any representation or warranty as to the reliability, completeness or accuracy of the information contained in this website. CHDPML does not accept liability for any inaccurate, incomplete or omitted information of any kind or any losses caused by using this information. Past performance is not a reliable indicator of future performance. Any forward-looking statement on this website is predictive in character and may be affected by inaccurate assumptions or by known or unknown risks and uncertainties and may differ materially from results ultimately achieved. All figures on this website are as at 30 June 2026 and in Australian dollars unless otherwise stated. © Charter Hall Group.

+13% p.a. target return*

+13% p.a. target return*

+13% p.a. target return*

Fund overview